113-Gene Signature May Predict Long-Term HCC Risk in NAFLD

TUESDAY, July 12, 2022 -- A 113-gene signature may predict long-term risk for incident hepatocellular carcinoma (HCC) in patients with nonalcoholic fatty liver disease (NAFLD), according to a study published online June 22 in Science Translational...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news